The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2020

Filed:

Oct. 28, 2016
Applicant:

New England Biolabs, Inc., Ipswich, MA (US);

Inventors:

Romualdas Vaisvila, Ipswich, MA (US);

Zhiyi Sun, Gloucester, MA (US);

Shengxi Guan, Ipswich, MA (US);

Lana Saleh, Hamilton, MA (US);

Laurence Ettwiller, Ipswich, MA (US);

Theodore B. Davis, Boxford, MA (US);

Assignee:

New England Biolabs, Inc., Ipswich, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12N 9/02 (2006.01); C12Q 1/6858 (2018.01); C12Q 1/6806 (2018.01); C12Q 1/6827 (2018.01); C12Q 1/6869 (2018.01); C12Q 1/6872 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6858 (2013.01); C12N 9/0071 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6869 (2013.01); C12Q 1/6872 (2013.01); C12Y 114/11 (2013.01); C12Q 2600/154 (2013.01);
Abstract

A method for identifying the location and phasing of modified cytosines (C) in long stretches of nucleic acids is provided. In some embodiments, the method may comprise (a) reacting a first portion of a nucleic acid sample containing at least one C and/or at least one modified C with a DNA glucosyltransferase and a cytidine deaminase to produce a first product and optionally reacting a second portion of the sample with a dioxygenase and a cytidine deaminase to produce a second product and; (b) comparing the sequences from the first and optionally the second product obtained in (a), or amplification products thereof, with each other and/or an untreated reference sequence to determine which Cs in the initial nucleic acid fragment are modified. A modified TET methylcytosine dioxygenase that is more efficient at converting methylcytosine to carboxymethylcytosine is also provided.


Find Patent Forward Citations

Loading…